Gregory Beecher
Analyst · Goldman Sachs
Thanks, Mark, and good morning, everyone. I'll start with the highlights of 2017 and then offer comments and perspective on 2018, including our capital allocation plans and the impact of the newly inactive tax laws. Also offer perspective on our strategic position and market trends of the business segment level, outline our new midterm financial model and close with the fourth quarter results and first quarter outlook. On the financial highlights front, as Mark noted, our $2.14 billion of sales in 2017 was up 22% from 2016, driven by a strong ATE market, SemiTest share gains and 72% sales growth at Universal Robots. As a result non-GAAP EPS was $2.34 for the year, up 55% from 2016 and exceeding our 2020 $2 EPS target three years early. In 2017, we performed quite nicely against our key attractive, we gain 2 points of share in SemiTest making 2017 the sixth consecutive year of ATE share gains. We grew Universal Robots top-line 72% well above the 50% threshold target. We had model operating performance in Wireless Test, mobile [ph] and Production Board Test. We also bought back 200 million of our stock at an average price of $34.30. Since the beginning of 2014, our balanced approach to capital allocation has returned $839 million to shareholders in buybacks and dividends and invested upwards of $350 million to acquire Universal Robots. When we bought Universal Robots in 2015, its sales for its recently completed year of 2014 were only $39 million. Over the subsequent three years they have grown over fourfold inside of Teradyne with sales of $170 million in 2017. With the new $1.5 billion share repurchase authorization we plan to repurchase a minimum $750 million of our stock in 2018. We increased quarterly dividend of 29% to $0.09 a quarter is effective immediately subject of course to ongoing Board approval. Our strong operating model and balance sheet comfortably support these moves on the operating model over the last two years we've average a 23% non-GAAP operating profit and $400 million of annual free cash flow. Over the next few years, we plan to steadily migrate our cash and marketable security balance of $1.9 billion down, while at the same time maintaining dry powder for attractive M&A subject of course to comparison against even more aggressive buybacks. We do see a number of attractive candidates in automation, particularly in software aimed at extending cobots into new applications. The newly inactive tax laws shift from the U.S., the U.S. from a global tax system to a territorial system, subject to a foreign minimum tax rate of 13.2%. As our foreign rate is estimated to be just above this threshold we do not expect to be subject to this new U.S. tax. With this change our 2000 tax rate is estimated at 15% versus our prior estimate of 19%. However, the new total tax on our accumulative foreign earnings will cost $150 million payable over eight years. Due to the lower U.S. federal tax rate we also wrote down our deferred tax assets by $34 million. These two onetime charges are included as discrete items in our Q4 GAAP results, but not in our non-GAAP results. Now looking at the segment level, annual highlights and trends. Starting with SemiTest we had another year of ATE market share gain adding 2 points to bring us to an estimated 50% share in 2017. These gains were in SOC test and more than offset the few points of decline in memory test share due to short-term volume shifts. We also score the number one spot in the VLSI survey for semiconductor equipment suppliers. Shifting to Universal Robots, we grew sales 72% from $99 million in 2016 to $170 million in 2017. Universal Robots also had an operating profit rate of 19% in 2017 more than doubled the 9% rate in 2016. Teradyne supply line group delivered several gross margin points of improvement and we can see further improvements as we move towards our target rate of 20% or better by 2020. Apart from the strong financial numbers, we strengthened Universal Robots' strategic positioned as Mark highlighted by growing our UR Plus ecosystem platform with more grippers, vision systems and other cobot accessories. This online platform is another key step and making it even easier to deploy our cobots and deliver a faster ROI. This easy access to proven solution reduces deployment time and project cost for our customers. We also opened up UR Academy, which is an online interactive training platform, offered in multiple languages, training is free and in less than 2 hours anyone can learn to train a UR cobot. The pattern that you no doubt see is that we're making it easier and easier to deploy our cobots. We along with third party research firms, expect 50% plus robust growth in the market for years to come. As the applications being served by cobots today are just scratch in the surface of what's possible. There are hundreds of highly repetitive task that are not well suited for people. For example, some repetitive tasks require very high precision such as applying the exact amount of glue or ergonomically challenging, such as driving screws with force or simply two TDS, such as machine tending or pick and place material handling. There are also new emerging technologies that should further extend the cobot served markets such as lower cost vision systems, for more advanced pick and place applications. So, the picture we see is that undesirable TDS task will be increasingly automated. And the human workers will be performing the higher skilled and safer task. And while we expect capable competitors to emerge, today the challenges are much more about building end user awareness. To that end, we'll have more robust digital and print awareness pieces along with a new digital lead generation problem in 2018. Shifting to System Test, our defense and aero and space and Production Board Test groups together grew 2017 sales 4% over 2016 and operated above model profitability for the second consecutive year. We expect similar performance in 2018 as defense and aero continues to benefit from the deployment of new weapon systems and new aircraft like the F35. While in Production Board Test our high throughput tester designed for high panel count applications, continues to gain traction in the growing automotive space. In Storage Test, we returned to model profitability in the second half of 2017 after incurring losses in the first half bringing to market a new product aimed at system level test of semiconductor devices. Storage test should operate at around $60 million sales and model profitability in 2018. Turning to Wireless Test, at LitePoint, the group rebounded very nicely from 2016 with sales growth of 16% and above model profitability in 2017. We expect 2018 to be similar to '17 as we position for a near-term market uptick, driven by the new 802.11ax wireless standard in 2019 and 5G cellular thereafter. For the full year, at the company level, non-GAAP gross margins of 57% were at record levels, an improvement of 2 points from 2016 due to higher volume and favorable product mix. Before moving to the more granular fourth quarter numbers, I'll note that after this call, we plan to no longer provide bookings information as the short-term timing of order placement adds unnecessary noise, with little added inside to our business. I also won't cover bookings in my prepared remarks, but the numbers can be found in the press release and investor desk. SemiTest sales were $317 million in the fourth quarter, with SOC making up $250 million and memory test the balanced at $67 million. SemiTest service revenue totaled $70 million. Universal Robots had sales of $54 million a quarterly record, geographically fourth quarter UR sales were 47% in Europe, 24% in Asia, 23% in North America and 6% in the rest of the world. Our largest channel partner was only 3% of our total 2017 sales, so again we have very wide diversity. System test sales were $80 million, up 125% from the third quarter, due to revenue recognition of our new system level test products and at wireless sales were $28 million. At the company level, our fourth quarter sales were $479 million. The non-GAAP operating profit rate was 23% and non-GAAP EPS was $0.46. We had nine 10% customer in the fourth quarter and 1% for the full year. Non-GAAP gross margins were 57% in the quarter with favorable product mix. You will see our non-GAAP operating expenses were down $3 million to $160 million compared to the third quarter due to lower variable compensation accruals on lower profits. Regarding our earnings power, when we set our original 2020 $2 EPS target, we conservatively estimated the ATE market would grow on average 1% annually from the 2014-15 average market size of $2.7 billion, after many years of sequential decline. Through 2017, the actual annual growth rate has been much stronger at 11% is a key reason why we achieved our $2 EPS target three years early. With that recent history, combined with our latest outlook, we've updated the earnings model target to $3.50 to $4 of non-GAAP EPS by 2021, driven by some very familiar themes. First is strong annual growth at Universal Roberts we've used 45% to 50% for modeling throw 2021, which would bring Universal Roberts to $750 million to $860 million in sales in the midterm. Next is further SemiTest growth any more modest than the last few years. We've modeled 3% to 4% growth rate from the 2014 average market size and a few points share gain through 2021. Finally repurchases, model performance and modest growth elsewhere will contribute to the EPS goal. We've detailed the new model in our investor deck. Looking a bit closer in at 2018 we expect grows margin to be approximately 56% to 57%. In OpEx in 2017 non-GAAP operating expenses were up $49 million versus 2016, driven principally by distribution investments in Universal Roberts and higher variable compensation tied to increased profitably. In our test businesses apart from normal changes is variable compensation tied to profit levels our total OpEx spending in 2017 was down slightly from 2016. Looking ahead to 2018 we plan to keep test OpEx flat apart from normal changes in variable compensation and to increase UR OpEx from $16 million a quarter exiting 2017 to upwards of $30 million a quarter by the end of 2018. These investments should strengthen both distribution and product development and help fuel another 50% plus growth year in 2018 and beyond. Shifting to our outlook for the first quarter, sales are expected to be between $460 million and $490 million, a 4% increase at the mid-point from the year ago first quarter sales of $457 million, the non-GAAP EPS range is $0.38 to $0.45 on $200 million diluted shares. Also please note that while we're confident of our full year 50% plus growth plan at UR, the first quarter revenue growth rate compared with last year will likely be lower than 50% due to the pricing related changes that drove very strong demand in the first quarter 2016. The first quarter guidance excludes the amortization of acquired intangibles and the non-cash imputed interest on the convertible debt first quarter gross margin are estimated 55% down 2 points in the fourth quarter due to product mix. The first quarter OpEx running at 34% to 36%, our first quarter sales is up about $5 million from the fourth quarter due to further distribution and product development investments at Universal Robots and some NRE project spending in SemiTest concentrated in the first quarter. The non-GAAP operating profit rate at the mid-point first quarter guidance is about 20%. Non-GAAP interest income excluding the non-cash imputed interest from the convert is expected to be about $2 million a quarter in 2018, factoring an interest income on our cast balances, partially offset by the 1.25% annual coupon on the convertible debt. In 2018 we've year marked $80 million to $100 million for CapEx. We start 2018 with fairly strong momentum after achieving our $2 2020 EPS target three years early and are forging a path to $3.50 to $4 of EPS by 2021. Rising device complexity, IC unit growth and increasing quality requirements are driving SemiTest, while Universal Robots is expected to grow at 50% plus for years to come our Wireless Test business is back to healthy profits and positioning for the next demand wave and we expect healthy performance in System Test. Layering top of that increased shareholders returns with our new $1.5 billion share repurchase program and a 29% increase to our quarterly dividends and the future of Teradyne looks quite bright. With that I'll turn the call back to Andy.